Stocks & Investing
Stocks and Investing
Stocks and Investing
Wed, October 23, 2019
[ Wed, Oct 23rd 2019
] - WOPRAI
Tue, October 22, 2019
[ Tue, Oct 22nd 2019
] - WOPRAI
[ Tue, Oct 22nd 2019
] - WOPRAI
[ Tue, Oct 22nd 2019
] - WOPRAI
[ Tue, Oct 22nd 2019
] - WOPRAI
[ Tue, Oct 22nd 2019
] - WOPRAI
[ Tue, Oct 22nd 2019
] - WOPRAI
[ Tue, Oct 22nd 2019
] - WOPRAI
[ Tue, Oct 22nd 2019
] - WOPRAI
[ Tue, Oct 22nd 2019
] - WOPRAI
[ Tue, Oct 22nd 2019
] - WOPRAI
[ Tue, Oct 22nd 2019
] - WOPRAI
[ Tue, Oct 22nd 2019
] - WOPRAI
[ Tue, Oct 22nd 2019
] - WOPRAI
[ Tue, Oct 22nd 2019
] - WOPRAI
[ Tue, Oct 22nd 2019
] - WOPRAI
[ Tue, Oct 22nd 2019
] - WOPRAI
[ Tue, Oct 22nd 2019
] - WOPRAI
[ Tue, Oct 22nd 2019
] - WOPRAI
[ Tue, Oct 22nd 2019
] - WOPRAI
[ Tue, Oct 22nd 2019
] - WOPRAI
[ Tue, Oct 22nd 2019
] - WOPRAI
[ Tue, Oct 22nd 2019
] - WOPRAI
[ Tue, Oct 22nd 2019
] - WOPRAI
Liana Moussatos Maintained (ASND) at Buy with Decreased Target to $186 on, Oct 22nd, 2019
Liana Moussatos of Wedbush, Maintained "Ascendis Pharma A/S" (ASND) at Buy with Decreased Target from $191 to $186 on, Oct 22nd, 2019.
Liana has made no other calls on ASND in the last 4 months.
There are 2 other peers that have a rating on ASND. Out of the 2 peers that are also analyzing ASND, 0 agree with Liana's Rating of Hold.
These are the ratings of the 2 analyists that currently disagree with Liana
- David Lebovitz of "Morgan Stanley" Initiated at Buy and Held Target at $128 on, Friday, October 11th, 2019
- Jessica Fye of "JP Morgan" Maintained at Buy with Increased Target to $152 on, Thursday, August 29th, 2019
